Join to View Full Profile
Stanford Cancer Clinic875 Blake Wilbur DriveStanford, CA 94305
Phone+1 650-723-7621
Dr. Horning is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Stanford Health Care-Sponsored Stanford UniversityFellowship, Medical Oncology, 1978 - 1980
University of Rochester Medical CenterResidency, Internal Medicine, 1975 - 1977
University of Iowa Roy J. and Lucille A. Carver College of MedicineClass of 1975
Certifications & Licensure
CA State Medical License 1978 - 2025
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 17 citationsFollicular lymphoma patients with KIR2DL2 and KIR3DL1 and their ligands (HLA-C1 and HLA-Bw4) show improved outcome when receiving rituximabAmy K. Erbe, Wei Wang, Lakeesha Carmichael, Anna Hoefges, Bartosz Grzywacz
Journal for Immunotherapy of Cancer. 2019-03-12 - 34 citationsRituximab extended schedule or retreatment trial for low tumour burden non-follicular indolent B-cell non-Hodgkin lymphomas: Eastern Cooperative Oncology Group Protoco...Michael E. Williams, Fangxin Hong, Randy D. Gascoyne, Lynne I. Wagner, John C. Krauss
British Journal of Haematology. 2016-06-01 - 21 citationsFc Gamma Receptor 3A and 2A Polymorphisms Do Not Predict Response to Rituximab in Follicular Lymphoma.Vaishalee P. Kenkre, Fangxin Hong, James R. Cerhan, Marcia Lewis, Leslie A. Sullivan
Clinical Cancer Research. 2016-02-15
Press Mentions
A Career in Biotechnology for Physicians and ScientistsMay 28th, 2022
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
